Literature DB >> 10333182

What is low vision? A re-evaluation of definitions.

S J Leat1, G E Legge, M A Bullimore.   

Abstract

PURPOSE: To re-evaluate definitions of low vision, visual impairment, and disability.
METHODS: We review current definitions of legal blindness and low vision and how these definitions are variably based on disability or impairment. We argue for a definite distinction being made between criteria for visual impairment and visual disability, low vision being defined as the presence of a visual impairment that results in a disability. Visual impairment is defined according to population norms and a statistical cut-off is used. Visual disability is defined by consideration of the level of visual measures which result in measurable or reportable disability. We consider the evidence that contrast sensitivity should be a criterion for visual disability in addition to visual acuity and visual field.
CONCLUSIONS: According to the current information, we define visual impairment as best monocular or binocular visual acuity <(worse than) 6/7.5, total horizontal visual field <146 degrees (Goldmann III-4e) or <109 degrees (III-3e), and contrast sensitivity <1.5 (PelliRobson); we define visual disability as best monocular or binocular visual acuity <6/12 or contrast sensitivity <1.05.

Entities:  

Mesh:

Year:  1999        PMID: 10333182     DOI: 10.1097/00006324-199904000-00023

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  22 in total

Review 1.  Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.

Authors:  Reiko E Sakai; Daniel J Feller; Kristin M Galetta; Steven L Galetta; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2011-12       Impact factor: 3.042

2.  Visual functions associated with on-road performance by older drivers evaluated by a certified driving rehabilitation specialist.

Authors:  Thomas A Swain; Gerald McGwin; Cynthia Owsley
Journal:  Ophthalmic Physiol Opt       Date:  2022-03-31       Impact factor: 3.992

Review 3.  Enhancing visual performance for people with central vision loss.

Authors:  Susana T L Chung
Journal:  Optom Vis Sci       Date:  2010-04       Impact factor: 1.973

4.  Prevalence and risk factors for eye diseases, blindness, and low vision in Lhasa, Tibet.

Authors:  Gui-Qin Wang; Zong-Xi Bai; Jing Shi; Sang Luo; Hong-Fa Chang; Xiao-Yong Sai
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

5.  How People with Low Vision Achieve Magnification in Digital Reading.

Authors:  Christina Granquist; Yueh-Hsun Wu; Rachel Gage; Michael D Crossland; Gordon E Legge
Journal:  Optom Vis Sci       Date:  2018-09       Impact factor: 1.973

Review 6.  Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.

Authors:  Joseph Kuchling; Alexander U Brandt; Friedemann Paul; Michael Scheel
Journal:  EPMA J       Date:  2017-07-25       Impact factor: 6.543

7.  Improving the legibility of prescription medication labels for older adults and adults with visual impairment.

Authors:  Susan J Leat; Abinaya Krishnamoorthy; Antonio Carbonara; Deborah Gold; Carlos Rojas-Fernandez
Journal:  Can Pharm J (Ott)       Date:  2016-04-11

8.  Reduced visual acuity is mirrored in low vision imagery.

Authors:  Aries Arditi; Gordon Legge; Christina Granquist; Rachel Gage; Dawn Clark
Journal:  Br J Psychol       Date:  2021-02-04

9.  Vision impairment and dual sensory problems in middle age.

Authors:  Piers Dawes; Christine Dickinson; Richard Emsley; Paul N Bishop; Karen J Cruickshanks; Mark Edmondson-Jones; Abby McCormack; Heather Fortnum; David R Moore; Paul Norman; Kevin Munro
Journal:  Ophthalmic Physiol Opt       Date:  2014-05-29       Impact factor: 3.117

Review 10.  Acute optic neuritis: Unmet clinical needs and model for new therapies.

Authors:  Steven L Galetta; Pablo Villoslada; Netta Levin; Kenneth Shindler; Hiroshi Ishikawa; Edward Parr; Diego Cadavid; Laura J Balcer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.